Cargando…
Identification of a Common Pharmacophore for Binding to MMP2 and RGD Integrin: Towards a Multitarget Approach to Inhibit Cancer Angiogenesis and Metastasis
During tumor angiogenesis different growth factors, cytokines and other molecules interact closely with each other to facilitate tumor cell invasion and metastatic diffusion. The most intensively studied as molecular targets in anti-angiogenic therapies are vascular endothelial growth factor (VEGF)...
Autores principales: | Baldini, Lorenzo, Lenci, Elena, Bianchini, Francesca, Trabocchi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879803/ https://www.ncbi.nlm.nih.gov/pubmed/35209039 http://dx.doi.org/10.3390/molecules27041249 |
Ejemplares similares
-
Molecular View
on the iRGD Peptide
Binding Mechanism: Implications for Integrin Activity and Selectivity
Profiles
por: D’Amore, Vincenzo Maria, et al.
Publicado: (2023) -
RGD-Binding Integrins in Head and Neck Cancers
por: Ahmedah, Hanadi Talal, et al.
Publicado: (2017) -
RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis
por: Sutherland, Mark, et al.
Publicado: (2012) -
Inhibition of the alpha-ν integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo
por: Buerkle, M A, et al.
Publicado: (2002) -
Consensus Ensemble Multitarget Neural Network Model of Anxiolytic Activity of Chemical Compounds and Its Use for Multitarget Pharmacophore Design
por: Vassiliev, Pavel M., et al.
Publicado: (2023)